Stay updated on ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM

Sign up to get notified when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.
Latest website image capture
Clouds background image

Latest updates to the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page

  1. Check
    2 days ago
    Change Detected
    Summary
    No content-level changes to core study details or eligibility criteria were detected; any detected differences appear to be minor UI/layout adjustments that do not affect the page's purpose. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:01:40.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Core content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:30:06.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Updated page content scope to include Multiple myeloma and bumped revision to v3.1.0, replacing the earlier specific topic (Plasma cell myeloma) and older version tag (v3.0.2).
    Difference
    0.4%
    Check dated 2025-09-29T03:05:47.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page revision now shows v3.0.2, replacing v3.0.1, indicating an updated version. The 'Back to Top' link was removed, with no changes to pricing, stock, or time slot information.
    Difference
    0.1%
    Check dated 2025-09-14T19:03:07.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Multiple myeloma under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.3%
    Check dated 2025-09-07T15:04:34.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location in Prague, Czechia, as well as new medical terms related to plasma cell myeloma and various chemical compounds. Notably, several previous terms and references related to multiple myeloma and specific drugs have been removed.
    Difference
    4%
    Check dated 2025-08-31T11:45:23.000Z thumbnail image

Stay in the know with updates to ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM

Enter your email address, and we'll notify you when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.